We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MURA
2776
DELISTED
Mural Oncology
MURA
| – | – |
-42,324
| Closed | -$207K |
|
2777
Murphy USA
MUSA
$11.3B
| – | – |
-600
| Closed | -$252K |
|
2778
Myriad Genetics
MYGN
$530M
| – | – |
-33,557
| Closed | -$715K |
|
2779
Myomo
MYO
$37.5M
| – | – |
-62,660
| Closed | -$205K |
|
2780
NCR Atleos
NATL
$3.52B
| – | – |
-70,957
| Closed | -$1.4M |
|
2781
Nature's Sunshine
NATR
$359M
| – | – |
-27,140
| Closed | -$564K |
|
2782
NB Bancorp
NBBK
$983M
| – | – |
-94,377
| Closed | -$1.29M |
|
2783
Neurocrine Biosciences
NBIX
$17.7B
| – | – |
-32,976
| Closed | -$4.55M |
|
2784
Norwegian Cruise Line
NCLH
$8.89B
| – | – |
-1,695,641
| Closed | -$35.5M |
|
2785
nCino
NCNO
$1.81B
| – | – |
-205,845
| Closed | -$7.69M |
|
2786
Nexa Resources
NEXA
$1.7B
| – | – |
-15,867
| Closed | -$114K |
|
2787
NovaGold Resources
NG
$2.6B
| – | – |
-152,445
| Closed | -$457K |
|
2788
National Health Investors
NHI
$3.9B
| – | – |
-7,639
| Closed | -$480K |
|
|
NINE
2789
DELISTED
Nine Energy Service
NINE
| – | – |
-186,863
| Closed | -$419K |
|
2790
Nike
NKE
$61.9B
| – | – |
-8,530
| Closed | -$793K |
|
2791
Nektar Therapeutics
NKTR
$2.39B
| – | – |
-98,082
| Closed | -$1.37M |
|
2792
NN Inc
NNBR
$272M
| – | – |
-100,618
| Closed | -$477K |
|
2793
NNN REIT
NNN
$9.39B
| – | – |
-5,601
| Closed | -$239K |
|
2794
Northern Oil and Gas
NOG
$2.3B
| – | – |
-45,835
| Closed | -$1.82M |
|
2795
NetApp
NTAP
$32.9B
| – | – |
-82,799
| Closed | -$8.69M |
|
2796
NETSCOUT
NTCT
$2.86B
| – | – |
-91,984
| Closed | -$2.01M |
|
2797
Intellia Therapeutics
NTLA
$1.5B
| – | – |
-335,408
| Closed | -$9.23M |
|
|
NVMI
2798
Nova
NVMI
$13.9B
| – | – |
-26,378
| Closed | -$4.68M |
|
|
NVNO
2799
enVVeno Medical
NVNO
$6.94M
| – | – |
-1,146
| Closed | -$218K |
|
2800
Novartis
NVS
$295B
| – | – |
-131,247
| Closed | -$12.7M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.